Arthritis drug shown to reduce risk of COVID death in large UK trial
More than 8,000 patients were administered baricitinib in addition to usual care, at random, or usual care alone, as part of the…
Author
Civica aims to launch low-cost insulin in US by 2024
Civica, launched in 2018 to make generic drugs, said it would produce three copycat versions of insulin
Pfizer to provide 10 million courses of COVID-19 pill to developing countries: Global Fund
The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed to at least that many doses, and could increase…
Roche teams up with research institutions for new Alzheimer’s trial
The trial aims to evaluate the potential of gantenerumab to slow disease progression in people with the earliest biological signs…
US FDA extends review period for expanded use of Abbvie’s psoriasis drug
The US Food and Drug Administration (FDA) was reviewing the application for the use of Skyrizi in patients aged 16 years or older…
US FDA approves cancer therapy by Johnson & Johnson and Legend Biotech
The treatment, Carvykti/Cilta-cel, belongs to a class of drugs known as CAR-T therapies, or chimeric antigen receptor T-cell…
US FDA approves CTI BioPharma’s bone marrow cancer drug
The drug, Vonjo (pacritinib), belongs to a class of anti-inflammatory treatments called JAK inhibitors, and will compete with…
US FDA declines to approve Amryt’s topical gel for rare skin diseases
The agency has asked Amryt to submit additional data confirming the effectiveness of the drug
AstraZeneca and Neurimmune ink $760 million deal for antibody drug
Under the agreement, Alexion would pay Neurimmune an upfront payment of $30 million and it would be eligible for payments of up to…
Inovio lab tests show COVID vaccine weaker against Omicron, trial enrollment paused
Inovio has paused enrollment in the trial to prepare for this potential change, and said interim efficacy data from the trial will…